@article {10.3844/ajisp.2013.43.47,
article_type = {journal},
title = {Placebo-Driven Clinical Trials of Transfer Point Glucan #300 in Children with Chronic Respiratory Problems: Antibody Production},
author = {Vaclav, Vetvicka and Josef, Richter and Vladimir, Svozil and Lucie, Rajnohova Dobiasova and Vlastimil, Kral},
volume = {9},
year = {2013},
month = {Jun},
pages = {43-47},
doi = {10.3844/ajisp.2013.43.47},
url = {https://thescipub.com/abstract/ajisp.2013.43.47},
abstract = {The role of glucan in stimulation of immune reactions has been well-established. In this report, we focused on the antibody production in glucan-supplemented children with chronic respiratory problems. We measured the levels of salivary IgA, IgM and IgG in 40 children aged 8-12 years and evaluated the effects of 100 mg d-1 oral dose of glucan. We found a significant increase in production of all tested antibodies in the glucan-stimulated group, but a decrease of antibody production in the control group. A thirty-day oral application of yeast-based natural immunomodulator β-glucan strongly stimulated the mucosal immunity of children with chronic respiratory problems.},
journal = {American Journal of Immunology},
publisher = {Science Publications}
}